Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock - $0.001 par value
-
Shares outstanding
-
10.6M
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
5.92M
-
Shares change
-
+59K
-
Total reported value, excl. options
-
$60.1M
-
Value change
-
+$673K
-
Number of buys
-
6
-
Number of sells
-
-9
-
Price
-
$10.15
Significant Holders of NEPHROS INC - Common Stock - $0.001 par value (NEPH) as of Q2 2021
19 filings reported holding NEPH - NEPHROS INC - Common Stock - $0.001 par value as of Q2 2021.
NEPHROS INC - Common Stock - $0.001 par value (NEPH) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.92M shares
of 10.6M outstanding shares and own 55.66% of the company stock.
Largest 10 shareholders include WEXFORD CAPITAL LP (3.63M shares), Cowen Prime Services LLC (626K shares), Cowen Prime Advisors LLC (626K shares), Samjo Capital LLC (549K shares), BARD ASSOCIATES INC (232K shares), VANGUARD GROUP INC (99.9K shares), HighTower Advisors, LLC (55.7K shares), BLAIR WILLIAM & CO/IL (36.2K shares), BlackRock Inc. (23.5K shares), and MILLENNIUM MANAGEMENT LLC (15K shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.